Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Calabresi

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Idrugs : the Investigational Drugs Journal|July 29, 2005
Social epidemiology, new therapeutics, lipid-lowering agents, growth factors and cytokinesL Calabresi
Idrugs : the Investigational Drugs Journal|July 5, 2005
PPARs - First International Symposium. From basic science to clinical applications. 4-7 April 2001, Florence, ItalyL Calabresi, M Gomaraschi
Current Opinion in Lipidology|August 1, 1997
High density lipoprotein and coronary heart disease: insights from mutations leading to low high density lipoproteinL Calabresi, G Franceschini
Pharmacological Research|June 27, 1998
Evidence-based medicine criteria applied to hypolipidemic and antihypertensive drug trials: is drug efficacy always the same?L Calabresi, C R Sirtori
Pharmacology & Therapeutics|January 1, 1994
Drug control of reverse cholesterol transportG Franceschini, J P Werba, L Calabresi
Progress in Clinical and Biological Research|January 1, 1988
Apolipoprotein AI-Milano: altered lipid binding properties in a human apolipoprotein variantG Franceschini, L Calabresi, C R Sirtori
Atherosclerosis|January 27, 1999
Recombinant apolipoproteins for the treatment of vascular diseasesC R Sirtori, L Calabresi, G Franceschini
Biochemistry|December 10, 1999
Cell cholesterol efflux to reconstituted high-density lipoproteins containing the apolipoprotein A-IMilano dimerL Calabresi, M Canavesi, F Bernini, et al.
Biochemical and Biophysical Research Communications|March 17, 1997
Activation of lecithin cholesterol acyltransferase by a disulfide-linked apolipoprotein A-I dimerL Calabresi, G Franceschini, A Burkybile, et al.
Biochimica Et Biophysica Acta|January 5, 1996
The molecular structure of apolipoprotein A-II modulates the capacity of HDL to promote cell cholesterol effluxF Bernini, L Calabresi, G Bonfadini, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Idrugs : the Investigational Drugs Journal|July 29, 2005
Social epidemiology, new therapeutics, lipid-lowering agents, growth factors and cytokinesL Calabresi
Idrugs : the Investigational Drugs Journal|July 5, 2005
PPARs - First International Symposium. From basic science to clinical applications. 4-7 April 2001, Florence, ItalyL Calabresi, M Gomaraschi
Current Opinion in Lipidology|August 1, 1997
High density lipoprotein and coronary heart disease: insights from mutations leading to low high density lipoproteinL Calabresi, G Franceschini
Pharmacological Research|June 27, 1998
Evidence-based medicine criteria applied to hypolipidemic and antihypertensive drug trials: is drug efficacy always the same?L Calabresi, C R Sirtori
Pharmacology & Therapeutics|January 1, 1994
Drug control of reverse cholesterol transportG Franceschini, J P Werba, L Calabresi
Progress in Clinical and Biological Research|January 1, 1988
Apolipoprotein AI-Milano: altered lipid binding properties in a human apolipoprotein variantG Franceschini, L Calabresi, C R Sirtori
Atherosclerosis|January 27, 1999
Recombinant apolipoproteins for the treatment of vascular diseasesC R Sirtori, L Calabresi, G Franceschini
Biochemistry|December 10, 1999
Cell cholesterol efflux to reconstituted high-density lipoproteins containing the apolipoprotein A-IMilano dimerL Calabresi, M Canavesi, F Bernini, et al.
Biochemical and Biophysical Research Communications|March 17, 1997
Activation of lecithin cholesterol acyltransferase by a disulfide-linked apolipoprotein A-I dimerL Calabresi, G Franceschini, A Burkybile, et al.
Biochimica Et Biophysica Acta|January 5, 1996
The molecular structure of apolipoprotein A-II modulates the capacity of HDL to promote cell cholesterol effluxF Bernini, L Calabresi, G Bonfadini, et al.
Pageof 7